IRIS
ARNALDI, DARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.806
Totale 11.806
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.806
Totale 11.806
Salva come PNG Salva come JPEG
Città #
Genova 7.240
Vado Ligure 1.638
Rapallo 1.454
Genoa 1.416
Bordighera 58
Totale 11.806
Salva come PNG Salva come JPEG
Nome #
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 175
A normative study of the Italian printed word version of the free and cued selective reminding test 154
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 152
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 149
Brain Functional Network in Alzheimer’s Disease: Diagnostic Markers for Diagnosis and Monitoring 137
Neuroimaging findings in mild cognitive impairment 134
Assessment of cognitive profile as a prodromal marker of the evolution of REM sleep Behavior Disorder 133
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 131
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 131
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 131
Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies. 130
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 127
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 127
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 127
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 126
What predicts cognitive decline in de novo Parkinson's disease? 123
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 118
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 117
Parkinson’s Disease Sleep Scale 2: application in an Italian population 117
Does postural rigidity decrease during REM sleep without Atonia in Parkinson disease? 117
Brain perfusion SPECT provides new insight on neurobiological effects of hyperbaric hyperoxia. 116
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 116
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 116
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 116
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 115
The role of the serotonergic system in REM sleep behavior disorder 115
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 115
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 115
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 114
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 114
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 114
Early identification of MCI converting to AD: a FDG PET study 113
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment 113
Integrating Sleep and Alzheimer's Disease Pathophysiology: Hints for Sleep Disorders Management 113
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 112
Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk? 111
Cortical Network Topology in Prodromal and Mild Dementia Due to Alzheimer’s Disease: Graph Theory Applied to Resting State EEG 110
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 108
The clinical relevance of cognitive impairment in REM sleep behavior disorder 107
Functional imaging in pre-motor Parkinson's disease 105
New tracers and new perspectives for molecular imaging in Lewy body diseases 105
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 104
Loss of REM sleep features across nighttime in REM sleep behavior disorder 102
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis 101
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 100
Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer's and Parkinson's diseases 100
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 100
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study 100
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 98
Progressive disgregation of brain networking from normal aging to Alzhimer's Disease. Independent Component Analysis on FDG-PET data 98
The prognostic value of sleep patterns in disorders of consciousness in the sub-acute phase 97
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder 96
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 96
Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts 95
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 94
A kinetics-based approach to amyloid PET semi-quantification 94
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 94
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 93
Metabolic patterns across core features in dementia with lewy bodies 92
Brain glucose metabolism heterogeneity in idiopathic REM sleep behavior disorder and in Parkinson's disease 92
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 92
Direct correlation between cardiac and striatal F-18-DOPA uptake in de novo Parkinson's disease 91
Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker 90
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 90
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 90
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 90
The pharmacotherapeutic management of obstructive sleep apnea 89
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 87
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms 87
Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies? 86
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 86
Getting the high school diploma with only one hemisphere: a case report 84
Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review. 83
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 83
Metabolic correlates of dopaminergic loss in dementia with lewy bodies 83
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 82
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 82
Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging. 80
Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data 77
Comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease 77
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 76
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 75
Neuroimaging Findings in Mild Cognitive Impairment 75
Lupus nephritis and Cyclic Vomiting Syndrome: a case report. 74
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 72
Abnormalities of Cortical Sources of Resting State Alpha Electroencephalographic Rhythms are Related to Education Attainment in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment 72
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 71
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 71
null 70
Utility of quantitative EEG in early Lewy body disease 70
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 70
Probing the Role of a Regional Quantitative Assessment of Amyloid PET 69
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project 69
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 68
null 67
Resting metabolic connectivity in Alzheimer's disease 66
Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers 66
Hyperconnectivity in Dementia Is Early and Focal and Wanes with Progression 66
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 64
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences 64
Totale 9.969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.592
article - articoli 44.377
book - libri 0
conference - conferenze 1.883
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.332
Totale 95.184
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.054 0 0 0 0 0 286 399 275 293 451 277 73
2020/20211.462 70 129 96 200 134 146 131 123 83 168 89 93
2021/20221.585 49 52 120 154 57 128 68 338 124 187 77 231
2022/20231.698 139 148 38 196 225 250 7 129 292 44 202 28
2023/20241.178 64 94 25 170 91 196 88 78 58 44 58 212
2024/20251.825 134 287 137 297 514 456 0 0 0 0 0 0
Totale 12.253